Interested parties can access a live webcast of the presentation directly by following this link. An archived webcast of the presentation will be available on the “Investors” section of the
Parties interested in registering for the Inaugural Gilmartin Group Emerging Growth Company Showcase may do so by following this link.
Iridex is a worldwide leader in developing innovative and versatile laser-based medical systems, delivery devices and consumable instrumentation for the ophthalmology market. The Company’s proprietary MicroPulse® technology delivers a differentiated treatment that provides safe, effective, and proven treatment for targeted sight-threatening eye conditions. Iridex’s current product line is used for the treatment of glaucoma, diabetic macular edema and other retinal diseases. Iridex products are sold in the United States and Germany through a direct sales force and in more than 100 countries through a network of independent distributors. For more information, visit www.iridex.com.
Investor Relations Contact:
Source: IRIDEX Corporation